These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32788679)

  • 1. Pharmaceutical firms commit US$1 billion to antibiotic development.
    Mullard A
    Nat Rev Drug Discov; 2020 Sep; 19(9):575-576. PubMed ID: 32788679
    [No Abstract]   [Full Text] [Related]  

  • 2. EU offers incentives to firms to produce medicines for children.
    Watson R
    BMJ; 2006 Jun; 332(7554):1352. PubMed ID: 16763236
    [No Abstract]   [Full Text] [Related]  

  • 3. Mergers in Japan help firms retain own products.
    Fuyuno I
    Nat Rev Drug Discov; 2005 May; 4(5):358. PubMed ID: 15902766
    [No Abstract]   [Full Text] [Related]  

  • 4. Billion dollar babies--biotech drugs as blockbusters.
    Lawrence S
    Nat Biotechnol; 2007 Apr; 25(4):380-2. PubMed ID: 17420735
    [No Abstract]   [Full Text] [Related]  

  • 5. The gold industry standard for risk and cost of drug and vaccine development revisited.
    Pronker ES; Weenen TC; Commandeur HR; Osterhaus AD; Claassen HJ
    Vaccine; 2011 Aug; 29(35):5846-9. PubMed ID: 21722688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. US drug sales continue to rise.
    Gottlieb S
    BMJ; 2003 Mar; 326(7388):518. PubMed ID: 12623895
    [No Abstract]   [Full Text] [Related]  

  • 7. Pricing pharmaceutical compounds under development.
    Dimitri N
    Trends Pharmacol Sci; 2014 May; 35(5):217-8. PubMed ID: 24439477
    [No Abstract]   [Full Text] [Related]  

  • 8. Deals landscape: notable deals in the pharmaceutical industry in the second quarter of 2008.
    Bright J; Lakeram M
    IDrugs; 2008 Aug; 11(8):584-91. PubMed ID: 18724496
    [No Abstract]   [Full Text] [Related]  

  • 9. Mega-mergers in the pharmaceutical industry. In whose interests?
    Po AL
    Pharmacoeconomics; 1998 Oct; 14(4):349-55. PubMed ID: 10344903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical industry financial performance.
    Goodman M
    Nat Rev Drug Discov; 2009 Dec; 8(12):927-8. PubMed ID: 19949398
    [No Abstract]   [Full Text] [Related]  

  • 11. New 2017 Data and Statistics for Pharmaceutical Products.
    Lindsley CW
    ACS Chem Neurosci; 2018 Jul; 9(7):1518-1519. PubMed ID: 30016875
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacoeconomic considerations in pharmaceutical company promotions.
    Goldstein AO; Ives TJ
    Arch Fam Med; 1994 Dec; 3(12):1034-5. PubMed ID: 7804487
    [No Abstract]   [Full Text] [Related]  

  • 13. [The philosophy of drug firms on drug pricing].
    Jolidon RM
    Rev Med Suisse; 2008 May; 4(159):1358-60. PubMed ID: 18592729
    [No Abstract]   [Full Text] [Related]  

  • 14. Repackaging.
    Prescrire Int; 2016 Jan; 25(167):10. PubMed ID: 26942252
    [No Abstract]   [Full Text] [Related]  

  • 15. Pandora's Prescription: The Pharmaceutical Pricing
    Pederson T
    FASEB J; 2017 Nov; 31(11):4661-4662. PubMed ID: 29093000
    [No Abstract]   [Full Text] [Related]  

  • 16. At a glance: economic impact of industry-sponsored clinical trials of pharmaceutical products.
    Varmaghani M; Heidari E; Reiner Ž; Sahebkar A
    J Med Econ; 2020 Oct; 23(10):1193-1195. PubMed ID: 32580595
    [No Abstract]   [Full Text] [Related]  

  • 17. Societal costs versus savings from wild-card patent extension legislation to spur critically needed antibiotic development.
    Spellberg B; Miller LG; Kuo MN; Bradley J; Scheld WM; Edwards JE
    Infection; 2007 Jun; 35(3):167-74. PubMed ID: 17565458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug industry is considering more use of differential pricing, conference hears.
    Sukkar E
    BMJ; 2011 Dec; 343():d8049. PubMed ID: 22155726
    [No Abstract]   [Full Text] [Related]  

  • 19. Link cost to clinical outcome.
    Norris J
    BMJ; 2007 May; 334(7601):968. PubMed ID: 17493992
    [No Abstract]   [Full Text] [Related]  

  • 20. Cheap drugs? Part 2: WHO intervenes.
    Ann Oncol; 2001 Apr; 12(4):426-7. PubMed ID: 11398869
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.